1,3,4-oxadiazole derivatives and their uses to treat diabetes

Details for Australian Patent Application No. 2009329345 (hide)

Owner AstraZeneca AB

Inventors Birch, Alan Martin; Pal, Sharmistha; Pettersen, Anna; Tomkinson, Gary Peter

Agent Davies Collison Cave

Pub. Number AU-A-2009329345

PCT Pub. Number WO2010/070343

Priority 61/139,032 19.12.08 US

Filing date 17 December 2009

Wipo publication date 24 June 2010

International Classifications

C07D 271/113 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

A61K 31/4245 (2006.01) - Oxadiazoles

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

30 June 2011 PCT application entered the National Phase

  PCT publication WO2010/070343 Priority application(s): WO2010/070343

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009329348-Binding members for interleukin-4 receptor alpha (IL-4Ra) - 836

2009329342-Spinal immobilisation